P-0282 * PKM2 EXPRESSION COULD PREDICT RESISTANCE TO OXALIPLATIN COMBINATION CHEMOTHERAPY IN PATIENTS WITH STAGE II/III OR METASTATIC COLORECTAL CANCER
Saridaki, Z., Papadaki, C., Tzardi, M., Sfakianaki, M., Sfakiotaki, G., Giagas, G., Messaritakis, I., Tsakalaki, E., Trypaki, M., Mavroudis, D., Georgoulias, V., Souglakos, J.Volume:
24
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdt203.280
Date:
June, 2013
File:
PDF, 33 KB
english, 2013